Vanguard Global Advisers’s Cytosorbents CTSO Stock Holding History
Bought
Maintained
Sold
Other funds holding CTSO
CM
Vanguard Global Advisers's CTSO Position: Q3 2026 in Review
Vanguard Global Advisers increased its Cytosorbents (CTSO) stake by 0.14% in Q3 2026, buying an estimated $7 and bringing the position to 694 shares worth $2.71K. The position accounts for ﹤0.01% of the portfolio, ranked #3641.
Vanguard Global Advisers first reported a position in CTSO in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.85K in Q1 2026. 28 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.
- Vanguard Global Advisers held 694 shares of Cytosorbents worth $2.71K as of Q3 2026.
- Vanguard Global Advisers bought 1 Cytosorbents share in Q3 2026, an estimated $7.
- Cytosorbents made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3641 holding.
- Vanguard Global Advisers first reported a position in Cytosorbents in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Cytosorbents position peaked at $7.85K in Q1 2026.
- 28 funds tracked by Wall St. Rank held Cytosorbents as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.